Catheter Precision Announces Convertible Preferred Financing

Catheter Precision, Inc. entered into a securities purchase agreement dated February 6, 2026 with multiple investors to purchase shares under a Regulation D exemption. The company authorized four new series of convertible preferred stock: Series C-1, Series C-2, Series C-3, and Series C-4, each with a stated value of $1,000 per share.

The preferred shares are convertible into Catheter Precision common stock, and the agreement contemplates a Registration Rights Agreement providing registration rights for registrable securities. The exhibit text also references a first closing and additional closings with share quantities set out on a Schedule of Buyers.